Back to search
FDAFDA · Food and drugs·Recall number D-0631-2021

Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13

Published June 23, 2021 · Recall initiated: June 9, 2021

Summary

FDA records drug Class III recall D-0631-2021, published June 23, 2021 and initiated June 9, 2021. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 10 cartons; Lot: Lot: 38617 Exp. 10/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Distributed in Los Angeles California
Lot
Lot: 38617 Exp. 10/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13 recalled?

Yes. FDA published recall D-0631-2021 on June 23, 2021. Reported hazard: Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

What should I do if I have this product?

Voluntary: Firm initiated · Letter